Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Cancer Science|October 26, 2022
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapyShoko Noda-Narita, Tomoyuki Naito, Hibiki Udagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2020
Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapyYusuke Okuma, Ryo Ko, Takehito Shukuya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.
Translational Lung Cancer Research|September 27, 2019
Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patientsAkihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, et al.
Clinical Lung Cancer|March 16, 2021
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine CarcinomaMasayuki Shirasawa, Tatsuya Yoshida, Daisuke Takayanagi, et al.
Cancer Science|May 11, 2023
Human resources for administrative work to carry out a comprehensive genomic profiling test in JapanHidenori Kage, Katsutoshi Oda, Manabu Muto, et al.
BMC Cancer|May 28, 2017
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604Yuki Misumi, Hiroaki Okamoto, Jiichiro Sasaki, et al.
Cancers|January 21, 2022
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 StudyTomoyasu Mimori, Takehito Shukuya, Ryo Ko, et al.
Thoracic Cancer|August 24, 2023
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesiclesMasahiro Torasawa, Hidehito Horinouchi, Shigehiro Yagishita, et al.
British Journal of Cancer|June 2, 2026
Role of VEGFA/VEGFR2 signaling in predicting clinical outcomes of EGFR-TKI treatment in EGFR-mutant non-small cell lung cancerRyoko Inaba Higashiyama, Tatsuya Yoshida, Kouya Shiraishi, et al.
Pageof 20